4/A

PRIMARY DOCUMENT

Company: ALNYLAM PHARMACEUTICALS, INC.
Filed: September 24, 2013
Period of Report: September 11, 2013
Accession Number: 0001325812-13-000005

View Document ↗ View on SEC.gov ↗